March 19, 2019
SFA Therapeutics Wins Second Key U.S. Patent For Treatment of Chronic Liver Diseases
Targets Liver Cancer JENKINTOWN, Pa.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/HCC?src=hash" target="_blank"gt;#HCClt;/agt;–SFA Therapeutics today announced approval of the second key U.S. patent derived from…